Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | Genmab A/S (GMAB.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 2,025.00 | 266.28 | 13.15% | 45.56 | 2.25% | NCAV (Net-Net) | 45.56 | 2.25% |
22 | ALK-Abello A/S (ALK B.CO) | XCSE | DK | 2023-12-31 | 5 days ago | DKK | 153.30 | 26.62 | 17.36% | 3.11 | 2.03% | NCAV (Net-Net) | 3.11 | 2.03% |
23 | Ambu A/S (AMBU B.CO) | XCSE | DK | 2023-09-30 | 1 day ago | DKK | 122.20 | 17.38 | 14.23% | 2.04 | 1.67% | NCAV (Net-Net) | 2.04 | 1.67% |
24 | Scandinavian Investment Group A/S (SIG.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 3.10 | 6.27 | 202.15% | 0.05 | 1.59% | NCAV (Net-Net) | 0.05 | 1.59% |
25 | Solar A/S (SOLAR B.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 341.50 | 645.32 | 188.97% | 5.34 | 1.56% | NCAV (Net-Net) | 5.34 | 1.56% |
26 | Coloplast A/S (COLO.B.CO) | 2019-09-30 | 3 years ago | DKK | 926.60 | 116.91 | 12.62% | 2.54 | 0.27% | NCAV (Net-Net) | 2.54 | 0.27% | ||
27 | Bactiquant A/S (BACTIQ.CO) | FNDK | DK | 2023-12-31 | 1 day ago | DKK | 3.33 | 0.00 | 0.00% | 0.30 | 8.97% | Ungraded | 0.00 | 0.00% |
28 | Tryg A/S (TRYG.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 143.20 | 86.20 | 60.19% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
29 | DFDS AS (DFDS.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 222.80 | 380.03 | 170.57% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
30 | Novo Nordisk A/S (NOVO B.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 909.90 | 85.93 | 9.44% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |